TY  - JOUR
AU  - Jiménez-Pérez, Miguel
AU  - González-Grande, Rocío
AU  - España Contreras, Pilar
AU  - Pinazo Martínez, Isabel
AU  - de la Cruz Lombardo, Jesús
AU  - Olmedo Martín, Raúl
PY  - 2016
DO  - 10.3748/wjg.v22.i29.6573
UR  - http://hdl.handle.net/10668/10378
T2  - World journal of gastroenterology
AB  - The use of direct-acting antivirals (DAAs) to treat chronic hepatitis C has resulted in a significant increase in rates of sustained viral response (around 90%-95%) as compared with the standard treatment of peginterferon/ribavirin. Despite this,...
LA  - en
KW  - Direct-acting antivirals
KW  - Hepatitis C virus
KW  - Resistance
KW  - Treatment
KW  - Antiviral Agents
KW  - Drug Resistance, Viral
KW  - Hepacivirus
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Treatment Failure
KW  - Viral Nonstructural Proteins
TI  - Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance.
TY  - research article
VL  - 22
ER  -